Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
Clinical trial NCT04610125 · UNKNOWN
Trial details
- NCT number
- NCT04610125
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2023-06-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.